A variety of viruses and bacteria can cause upper respiratory tract infections including acute bronchitis, the common cold, influenza, and respiratory distress syndromes.
• Defining most of these patient diseases is difficult because the presentations connected with upper respiratory tract infections (URIs) commonly overlap and their causes are similar.
• Upper respiratory tract infections can be defined as self-limited irritation and swelling of the upper airways with associated cough with no proof of pneumonia, lacking a separate condition to account for the patient symptoms, or with no history of COPD/emphysema/chronic bronchitis. Influenza Viruses
• Small hairs (cilia) in the sinuses fail to properly move mucus out. This may be due to some medical conditions.
• Colds and allergies may cause too much mucus to be made or block the opening of the sinuses.
• A deviated nasal septum, nasal bone spur, or nasal polyps may block the opening of the sinuses.
Why should you do the Skin Prick Test?
SPT is an essential test procedure to find sensitization in IgE-mediated allergic disease in subjects with Hay fever (allergic rhinitis), asthma, rhinoconjunctivitis, Dermatitis (eczema), anapylaxis, urticaria, atopic eczema and food and drug allergy.
Procedure for skin prick test
This is not a painful test. A needle(lancet) is used to prick your skin during the test which is not at all painful or you lose any blood. Follow are the steps of the test.
• Your skin is cleaned by alcohol
• A nurse/technician marked your skin and put a drop of allergen beside every mark
• Using a lancet the technician pricks your skin to allow a tiny amount of the solution to enter just below the surface
• Now you should wait for a specific amount of time. Usually 30 min.
• Now your allergist checks the marks for a observes your skin for signs of allergic reactions. If you are allergic to one of the substances tested, you’ll develop a raised, red, itchy bump (wheal) that may look like a mosquito bite. A nurse will then measure the bump’s size.
• After the recording of the result, the nurse/technician clean your testing surface with alcohol
A variety of viruses and bacteria can cause upper respiratory tract infections including acute bronchitis, the common cold, influenza, and respiratory distress syndromes.
• Defining most of these patient diseases is difficult because the presentations connected with upper respiratory tract infections (URIs) commonly overlap and their causes are similar.
• Upper respiratory tract infections can be defined as self-limited irritation and swelling of the upper airways with associated cough with no proof of pneumonia, lacking a separate condition to account for the patient symptoms, or with no history of COPD/emphysema/chronic bronchitis. Influenza Viruses
• Small hairs (cilia) in the sinuses fail to properly move mucus out. This may be due to some medical conditions.
• Colds and allergies may cause too much mucus to be made or block the opening of the sinuses.
• A deviated nasal septum, nasal bone spur, or nasal polyps may block the opening of the sinuses.
Why should you do the Skin Prick Test?
SPT is an essential test procedure to find sensitization in IgE-mediated allergic disease in subjects with Hay fever (allergic rhinitis), asthma, rhinoconjunctivitis, Dermatitis (eczema), anapylaxis, urticaria, atopic eczema and food and drug allergy.
Procedure for skin prick test
This is not a painful test. A needle(lancet) is used to prick your skin during the test which is not at all painful or you lose any blood. Follow are the steps of the test.
• Your skin is cleaned by alcohol
• A nurse/technician marked your skin and put a drop of allergen beside every mark
• Using a lancet the technician pricks your skin to allow a tiny amount of the solution to enter just below the surface
• Now you should wait for a specific amount of time. Usually 30 min.
• Now your allergist checks the marks for a observes your skin for signs of allergic reactions. If you are allergic to one of the substances tested, you’ll develop a raised, red, itchy bump (wheal) that may look like a mosquito bite. A nurse will then measure the bump’s size.
• After the recording of the result, the nurse/technician clean your testing surface with alcohol
Het gemeentebestuur van Hamme, in samenwerking met vzw Ondernemend Hamme, de dienst lokale economie, de communicatiedienst en de firma PUBLI-touch, heeft beslist een gemeentelijke informatiegids uit te geven in het voorjaar van 2015.
In deze gids die door de Post in ongeveer 11.500 gezinnen van onze gemeente wordt verdeeld, vindt u niet alleen een uitgebreid overzicht van de gemeentelijke diensten, maar kan u ook van andere (externe) diensten de contactgegevens terugvinden.
In de editie 2015-2016 krijgt ook het Hamse bedrijfs- en handelsleven opnieuw een centrale plaats. De
handelaars zullen de gelegenheid krijgen in deze brochure te adverteren. De invulling en afwerking van
deze publicitaire opdracht gebeuren uitsluitend onder de verantwoordelijkheid van de firma PUBLI-touch, vertegenwoordigd door de heren Jan Duchau (tel. 0498 36 15 31 - jan@inforegio.be) en
Etienne Duchau (tel. 0495 54 77 56).
Het gemeentebestuur zal enkel aan dit initiatief van de firma PUBLI-touch zijn medewerking verlenen en
niet ingaan op om het even welk ander commercieel initiatief. Het wil op die manier voorkomen dat
meerdere keren per jaar een beroep wordt gedaan op handelaars, vrije beroepers en bedrijven.
Google Panda and Penguine: A quick SummaryRahul Kumar
We have covered complete information about Google Panda & Penguin Algorithm update of Google. How it Works? Which Site it damages? And how to recover? Call at +91-782-774-2414 if you have any query or know more.
Creating Management Summaries Using CA 7 Reports - CA Workload Automation Tec...Extra Technology
Please get in touch via Extra Technology's contact page - http://www.extratechnology.com/contact - to learn more about CA Technologies' Workload Automation products and to book your place at the next WATS event.
This 'Creating Management Summaries Using CA 7 Reports' presentation was delivered by CA Technologies' Bill Sherwin at the 'CA Workload Automation Technology Summit (WATS) 2014' in London, October 2014.
Since 2013 the UK User Group meetings for CA 7, AutoSys & dSeries have been incorporated into WATS. Customers agree that WATS is a must-attend event for the CA Workload Automation community, showcasing CA's latest CA 7 solutions including CA 7 Web Client and iDash advanced workload analytics tool (that delivers real-time forecasting & critical path analysis, automated recovery procedures, alerts on threshold exceptions for easier troubleshooting, comprehensive historical reporting and performance monitoring with rich graphics).
WATS is a free-of-charge event, sponsored and arranged by Workload Automation experts Extra Technology. It features guest speakers from CA Technologies, Extra Technology and other SMEs.
Quote burgemeester ''Een gemeentegids is niet volledig zonder advertenties van de handelaars, bedrijven, instellingen, vrije beroepen, en zelfstandige ondernemers in dienst- en/of goederenverlening. Immers ook zij zorgen voor de informatie, waaraan in het bijzonder nieuwe inwoners behoefte hebben.'' Een mooiere omschrijving konden wij niet wensen als onderdeel van onze legitimatie. Dank hiervoor en hopelijk tot een volgende publicatie Moorslede ;-) Jan Duchau - 0498/361 531 - jan@inforegio.be
Het platform Dag Zonder Krediet pleit ervoor dat het arsenaal aan wetten ter bescherming van de consumenten niet louter een bescherming « op papier » zou bieden.
Onze aanbevelingen hebben betrekking op drie aspecten van de problematiek :
Deel 1. De bescherming van de consument tegen misleidende en bedrieglijke commerciële praktijken, o.a. in het kader van reclames
Deel 2. Het informeren van de consument tijdens de contractuele fase
Deel 3. De uitgebreide en vereenvoudigde mogelijkheden voor de consument om verhaal te halen
This presentation is about Emphysema and Chronic Bronchitis made by CHAKRAPANI BHUVANESH.
Bronchitis is an inflammation of the lining of your bronchial tubes, which carry air to and from your lungs. People who have bronchitis often cough up thickened mucus, which can be discolored. Bronchitis may be either acute or chronic.
Module: Pharmacology and Therapeutics III, (Therapeutics part)
Coordinator: Dr. Arwa M. Amin Mostafa
Academic Level: Undergraduate, B.Pharmacy
School: Dubai Pharmacy College
Year of first presented in Class: 2018
This presentation is for Educational purpose. It has no commercial value associated with it.
BRONCHIECTASIS approach and treatment by Dr.Amira TabidiAmira30013
Pulmonolgy ,it's a common respiratory air way disease with many radiogical features that's vital to learn about it so you can reach the diagnosis easily along with a solid clinical approach
Understanding the bronchiectasis prognosisSugeng Hartono
Understanding the Bronchiectasis Prognosis Now! Here!
The article below will discuss the bronchiectasis prognosis of in a complete and detailed.
Before you find out about the bronchiectasis prognosis, would be better if you also have to know some things about bronchiectasis such as epidemiology, definition, and fatofisiologi Pathogenesis, pathology, etiology and predisposing factors, clinical features, clinical manifestations, physical examination, diagnosis and treatment of bronchiectasis.
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. Bronchitis is inflammation
of the mucous membranes
of the bronchi.
There are two basic types
of bronchitis - acute and
chronic.
3. Acute bronchitis is characterized by the
development of a cough, with or without
the production of sputum.
4. It often occurs during the course
of an acute viral illness such as
the common cold or influenza.
5. Chronic bronchitis, a type of chronic
obstructive pulmonary disease, is
characterized by the presence of a
productive cough.
6. Chronic bronchitis most often develops
due to recurrent injury to the airways
caused by inhaled irritants.
7. Bronchopneumonia is a common
inflammation of the lung.
Inflammation starts in bronchioles,
and spreads to the peribronchiolar
alveoli and alveolar ducts.
8. The result is that the inflammatory
changes lead to the localized
inflammatory consolidation in
bronchioles and their surrounding
alveoli of the lungs.
9. Most of the time, bronchopneumonia is
caused by bacterial infection.
10. It often occurs in human due to
the lower body resistance and
the impaired defense function
of the respiratory tract.
11. Cough and coughing
up phlegm are both
the main symptoms of
bronchopneumonia.
Having fever and shortness
of breath are also common.
12. Lung cancer is a disease that consists of
uncontrolled cell growth in tissues of the lung.
13. The main types of lung cancer are
small-cell lung carcinoma and non-small-
cell lung carcinoma.
14. The most common cause of lung cancer is
long-term exposure to tobacco smoke.
There are non-smokers who also suffer
from lung cancer.
15. Lung cancer may be seen on chest radiograph
and computed tomography. The diagnosis is
confirmed with a biopsy.
16. Treatment and prognosis depend upon
the histological type of cancer, the stage
and the patient's performance status.
17. Possible treatments include surgery,
chemotherapy, and radiotherapy.
Survival varies, depending on stage,
overall health, and other factors.